Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 358

2.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

PMID:
18957670
3.

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL.

J Natl Cancer Inst. 2003 Mar 19;95(6):448-57.

PMID:
12644538
4.

Age at onset as an indicator of familial risk of breast cancer.

Claus EB, Risch NJ, Thompson WD.

Am J Epidemiol. 1990 Jun;131(6):961-72.

PMID:
2188501
5.
6.
7.

Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins.

Baker SG, Lichtenstein P, Kaprio J, Holm N.

Biometrics. 2005 Mar;61(1):55-63.

PMID:
15737078
8.

A population genetic study of psoriasis.

Swanbeck G, Inerot A, Martinsson T, Wahlström J.

Br J Dermatol. 1994 Jul;131(1):32-9.

PMID:
8043420
9.

Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study.

Simon MS, Korczak JF, Yee CL, Malone KE, Ursin G, Bernstein L, McDonald JA, Deapen D, Strom BL, Press MF, Marchbanks PA, Burkman RT, Weiss LK, Schwartz AG.

J Clin Oncol. 2006 Jun 1;24(16):2498-504.

PMID:
16735703
10.

Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.

Kaufman DJ, Beaty TH, Struewing JP.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1045-52.

11.

Familial segregation of venous thromboembolism.

Heit JA, Phelps MA, Ward SA, Slusser JP, Petterson TM, De Andrade M.

J Thromb Haemost. 2004 May;2(5):731-6.

12.
13.

The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.

Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.

Breast Cancer Res. 2005;7(3):R353-6. Epub 2005 Mar 4.

14.

Disease family history and modification of breast cancer risk in common BRCA2 variants.

Seymour IJ, Casadei S, Zampiga V, Rosato S, Danesi R, Falcini F, Strada M, Morini N, Naldoni C, Paradiso A, Tommasi S, Schittulli F, Amadori D, Calistri D.

Oncol Rep. 2008 Mar;19(3):783-6.

PMID:
18288416
15.

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.

J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.

PMID:
16418514
16.

Validation of family history data in cancer family registries.

Ziogas A, Anton-Culver H.

Am J Prev Med. 2003 Feb;24(2):190-8.

PMID:
12568826
17.

Familial risk of breast cancer in a French case-control study.

Andrieu N, Clavel F, Gairard B, Piana L, Brémond A, Lansac J, Flamant R, Renaud R.

Cancer Detect Prev. 1994;18(3):163-9.

PMID:
8076378
18.

Timing of familial breast cancer in sisters.

Rebora P, Czene K, Reilly M.

J Natl Cancer Inst. 2008 May 21;100(10):721-7. doi: 10.1093/jnci/djn146. Epub 2008 May 13.

PMID:
18477799
19.

Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.

Valeri A, Briollais L, Azzouzi R, Fournier G, Mangin P, Berthon P, Cussenot O, Demenais F.

Ann Hum Genet. 2003 Mar;67(Pt 2):125-37.

PMID:
12675688
20.

The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.

Skasko E, Paszko Z, Niwińska A, Kwiatkowska E, Kruczek A, Pieńkowski T.

Eur J Gynaecol Oncol. 2004;25(4):470-4.

PMID:
15285306

Supplemental Content

Support Center